Bio-Techne (TECH) Capital Expenditures (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.45% |
| Dec 31, 2025 | 10.40% |
| Sep 30, 2025 | 9.67% |
| Jun 30, 2025 | -51.69% |
| Mar 31, 2025 | 48.41% |
| Dec 31, 2024 | -25.63% |
| Sep 30, 2024 | -48.99% |
| Jun 30, 2024 | 9.36% |
| Mar 31, 2024 | 10.61% |
| Dec 31, 2023 | 9.36% |
| Sep 30, 2023 | 25.49% |
| Jun 30, 2023 | -7.81% |
| Mar 31, 2023 | 92.31% |
| Dec 31, 2022 | -36.07% |
| Sep 30, 2022 | -29.58% |
| Jun 30, 2022 | -10.13% |
| Mar 31, 2022 | 48.51% |
| Dec 31, 2021 | 67.51% |
| Sep 30, 2021 | -46.36% |
| Jun 30, 2021 | 6.73% |
| Mar 31, 2021 | -7.37% |
| Dec 31, 2020 | 4.64% |
| Sep 30, 2020 | -37.04% |
| Jun 30, 2020 | 87.17% |
| Mar 31, 2020 | -36.27% |
| Dec 31, 2019 | 38.38% |
| Sep 30, 2019 | -9.98% |
| Jun 30, 2019 | 137.40% |
| Mar 31, 2019 | 6.97% |
| Dec 31, 2018 | 9.88% |
| Sep 30, 2018 | -27.98% |
| Jun 30, 2018 | 65.85% |
| Mar 31, 2018 | -44.63% |
| Dec 31, 2017 | 20.14% |
| Sep 30, 2017 | -10.14% |
| Jun 30, 2017 | 46.12% |
| Mar 31, 2017 | 40.76% |
| Dec 31, 2016 | 16.83% |
| Sep 30, 2016 | -20.04% |
| Jun 30, 2016 | 7.69% |
| Mar 31, 2016 | -41.97% |
| Dec 31, 2015 | -20.16% |
| Sep 30, 2015 | -11.72% |
| Jun 30, 2015 | 40.82% |
| Mar 31, 2015 | 56.72% |
| Dec 31, 2014 | -35.94% |
| Sep 30, 2014 | 133.35% |
| Jun 30, 2014 | -50.67% |
| Mar 31, 2014 | 16.84% |
| Dec 31, 2013 | -4.30% |
| Sep 30, 2013 | -28.71% |
| Jun 30, 2013 | -16.11% |
| Mar 31, 2013 | -22.47% |
| Dec 31, 2012 | 226.84% |
| Sep 30, 2012 | 121.98% |
| Jun 30, 2012 | -28.61% |
| Mar 31, 2012 | -27.90% |
| Dec 31, 2011 | 100.82% |
| Sep 30, 2011 | -13.90% |
| Jun 30, 2011 | 115.03% |
| Mar 31, 2011 | -16.97% |
| Dec 31, 2010 | -32.22% |
| Sep 30, 2010 | -6.32% |
| Jun 30, 2010 | -17.79% |
| Mar 31, 2010 | -14.20% |
| Dec 31, 2009 | 182.77% |